<DOC>
	<DOCNO>NCT02348333</DOCNO>
	<brief_summary>The purpose study assess safety , tolerability , pharmacokinetics pharmacodynamics 7-day-repeated dos FYU-981 administer orally healthy male adult daily . Participants randomize placebo ( n=3 ) FYU-981 ( n=6 ) step . After follow-up examination step lower dose , next dose administer .</brief_summary>
	<brief_title>Repeated Dose Phase I Study FYU-981</brief_title>
	<detailed_description />
	<criteria>Japanese healthy adult subject Body mass index : &gt; =18.5 &lt; 25.0 Subjects disease history disease might unsuitable participation clinical study</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>January 2015</verification_date>
</DOC>